Cortendo AB

http://www.cortendo.com/

Last activity: 03.09.2015

Active

Mentions

Overview

Total raised

$53.9M

Funding Rounds 2

Date	Series	Amount	Investors
Sign up to see	Sign up to see	Sign up to see	Sign up to see
	Funding round	$27.5M

Mentions in press and media 24

Date	Title	Description
Sign up to see	Sign up to see	Sign up to see
Mar 11, 2015	Cortendo Reports Results and Activities for the Fourth Quarter and Full Year 2014	GÖTEBORG, Sweden & RADNOR, Pa.–(BUSINESS WIRE)–March 11, 2015– Cortendo AB: Highlights – Q4 2014 and Post Period Cortendo closed two private placement financings totaling approximately SEK 302 million ($37 million) during Q4 2014 and Q1...
Feb 27, 2015	Cortendo Announces Proposed Changes to Board of Directors	GÖTEBORG, Sweden & RADNOR, Penn.–(BUSINESS WIRE)–February 27, 2015– Cortendo AB (publ) [ticker: CORT on NOTC-A], a global biopharmaceutical company focused on orphan endocrine disorders, today announced changes to the Company’s board of...
Feb 26, 2015	Cortendo to Present at Upcoming Investor Conferences	GÖTEBORG, Sweden & RADNOR, Penn.–(BUSINESS WIRE)–February 26, 2015– Cortendo AB [ticker: CORT on NOTC-A], a global biopharmaceutical company focused on orphan endocrine disorders, today announced President and CEO Matthew Pauls will pre...
Feb 23, 2015	Cortendo to Join Patients, Families and Pennsylvania Legislators to Raise Awareness for Rare Diseases	HARRISBURG, Pa.–(BUSINESS WIRE)–February 23, 2015– Cortendo AB [ticker: CORT on NOTC-A], a global biopharmaceutical company focused on developing new solutions for rare diseases that is based in Radnor, Penn., is pleased to participate in t...
Feb 11, 2015	Cortendo Completes $26.4M in Private Placement from Leading U.S. and EU Investors	GÖTEBORG, Sweden & RADNOR, Pa.–(BUSINESS WIRE)–February 11, 2015– Cortendo AB [ticker: CORT on NOTC-A], a global biopharmaceutical company focused on orphan endocrine disorders, today announced that it closed a previously announced priv...
Jan 29, 2015	COR-003 Phase 3 Study Protocol to be Presented at ENDO 2015: The Endocrine Society’s 97th Annual Meeting & Expo	RADNOR, Pa. & GÖTEBORG, Sweden–(BUSINESS WIRE)–January 29, 2015– Cortendo AB [ticker: CORT on NOTC-A], a global biopharmaceutical company initially focused on orphan endocrine disorders, today announced that it will present the study pr...
Jan 28, 2015	The Journal Diabetes Publishes Pre-clinical Data on Cortendo’s Novel Diabetes Treatment, BP-2001	GÖTEBORG, Sweden & RADNOR, Penn.–(BUSINESS WIRE)–January 28, 2015– Cortendo AB [ticker: CORT on NOTC-A], a global biopharmaceutical company focused on orphan endocrine disorders, is pleased to announce that the journal Diabetes publishe...
Jan 13, 2015	Cortendo AB Raises up to $27.5M in Additional Private Placement with Leading U.S. and EU Healthcare Investors	RA Capital, NEA, Broadfin Capital Make Initial Investments; HealthCap Adds to Its Holdings of Cortendo; Total Raised Since October up to $38.5M RADNOR, Pa. & GÖTEBORG, Sweden–(BUSINESS WIRE)–January 13, 2015– Cortendo AB [ticker: CORT o...
Oct 30, 2014	Cortendo Announces HealthCap Leads $11M (NOK 73.4M) Private Placement	Company to Evaluate U.S. Financing and Listing Strategy RADNOR, Pa.& GÖTEBORG, Sweden–(BUSINESS WIRE)–October 30, 2014– Cortendo AB [ticker: CORT on NOTC-A], a global biopharmaceutical company focused on orphan endocrine disorders, toda...
	Cortendo Announces Proposed Changes to Board of Directors	February 27, 2015 — Göteborg, Sweden and Radnor, Penn., USA — Cortendo AB(publ) [ticker: CORT on NOTC-A], a global biopharmaceutical company focused on orphan endocrine disorders, today announced changes to the Company’s board of directors ...
	Cortendo AB Raises up to $27.5M in Additional Private Placement with Leading U.S. and EU Healthcare Investors	RA Capital, NEA, Broadfin Capital Make Initial Investments; HealthCap Adds to Its Holdings of Cortendo; Total Raised Since October up to $38.5M January 13, 2015 — Radnor, Penn., U.S. and Göteborg, Sweden — Cortendo AB [ticker: CORT on NOTC...
	Cortendo Announces HealthCap Leads $11M (NOK 73.4M) Private Placement	October 30, 2014 — Radnor, Penn., U.S. and Göteborg, Sweden — Cortendo AB [ticker: CORT on NOTC-A], a global biopharmaceutical company focused on orphan endocrine disorders, today announced that it has entered into an agreement (“Agreement”...
	Cortendo Adds Two Late-Stage Assets to Its Rare Endocrine Disease Franchise and Announces Related $33.2 Million Financing	Cortendo Enters Into Agreements to Acquire Aspireo Pharmaceuticals’ Somatoprim (DG3173) and In-License Antisense Therapeutics’ ATL1103 Cortendo Expands Investor Base Through New Private Placement May 15, 2015 – Göteborg, Sweden and Trevos...
	Cortendo AB Joins National Organization for Rare Disorders (NORD)® Corporate Council	Leaders in Rare Disease Community Unite for National Cushing’s Syndrome Awareness Day on April 8 RADNOR, Pa. and DANBURY, Conn., April 8, 2015 – Cortendo AB (publ) [ticker: CORT on NOTC-A], a global biopharmaceutical company focused on rar...
	Cortendo AB Announces Appointments of A. Brian Davis as Chief Financial Officer and Stephen Long as Chief Legal Officer	March 23, 2015 – Göteborg, Sweden and Radnor, Pa., USA — Cortendo AB (publ) [ticker: CORT on NOTC-A], a global biopharmaceutical company focused on orphan endocrine disorders and other rare diseases, today announced the appointments of A. B...
	Cortendo Announces Plans to Redomicile the Cortendo Group’s Parent Company from Sweden to Ireland By Means of an Exchange Offer	August 3, 2015 – Göteborg, Sweden and Trevose, Pa., USA – Cortendo AB (publ) [ticker: CORT on NOTC-A] (the “Company”) today announced its intention to relocate the parent company of the Cortendo group from Sweden to Ireland. The Company is ...
	Cortendo Announces Plans to Conduct Registered Initial Public Offering of Its Common Shares	July 20, 2015 – Göteborg, Sweden and Trevose, Pa., USA – Cortendo AB (publ) [ticker: CORT on NOTC-A] today announced that the Company plans to conduct a registered initial public offering of common shares in the United States. This announc...
	The Journal Diabetes Publishes Pre-clinical Data on Cortendo’s Novel Diabetes Treatment, BP-2001	January 28, 2015 — Göteborg, Sweden and Radnor, Penn., USA – Cortendo AB [ticker: CORT on NOTC-A], a global biopharmaceutical company focused on orphan endocrine disorders, is pleased to announce that the journal Diabetes published a scient...
	Cortendo Provides 2015 Half-Year Update on Corporate Progress	Cortendo Expands Board of Directors and Management Team Cortendo Provides Update on COR-003 Phase 3 Clinical Development Program Cortendo Builds Rare Endocrine Disease Franchise with Completion of Transactions for Two-Late Stage Assets C...
	Cortendo to Join Patients, Families and Pennsylvania Legislators to Raise Awareness for Rare Diseases	February 23, 2015 — Harrisburg, PA, USA – Cortendo AB [ticker: CORT on NOTC-A], a global biopharmaceutical company focused on developing new solutions for rare diseases that is based in Radnor, Penn., is pleased to participate in the Rare D...
	Cortendo to Present at the 17th Annual BIO CEO & Investor Conference	February 2, 2015 – Göteborg, Sweden and Radnor, Penn., USA — Cortendo AB [ticker: CORT on NOTC-A], a global biopharmaceutical company initially focused on orphan endocrine disorders, today announced that Matthew Pauls, President and CEO, wi...
	Cortendo and Antisense Therapeutics Announce Licensing Agreement for ATL1103 for Acromegaly	May 14, 2015 – Goteborg, Sweden and Trevose, Pa., USA and Victoria, Australia – Cortendo AB (publ) [ticker: CORT on NOTC-A], a biopharmaceutical company focused on rare endocrine disorders and other rare diseases, and Antisense Therapeutics...
	Cortendo Completes $26.4M in Private Placement from Leading U.S. and EU Investors	February 11, 2015 — Göteborg, Sweden and Radnor, Penn., USA — Cortendo AB [ticker: CORT on NOTC-A], a global biopharmaceutical company focused on orphan endocrine disorders, today announced that it closed a previously announced private plac...

Reviews 0

FAQ about Cortendo AB

How much funding has Cortendo AB raised?

Cortendo AB has raised $53.9M in total across 2 funding rounds.

What has the press written about Cortendo AB?

Parsers VC has collected 24 articles mentioning Cortendo AB, among them “Cortendo Reports Results and Activities for the Fourth Quarter and Full Year 2014” (Mar 11, 2015) and “Cortendo Announces Proposed Changes to Board of Directors” (Feb 27, 2015).

Is Cortendo AB still active?

Yes, Cortendo AB is active; its latest activity on Parsers VC dates from Sep 3, 2015.